Bookmark
Forward
Natalizumab for GVHD: too little or too late?
Kevin Quann, Faruk Sacirbegovic, Warren D Shlomchik
Blood advances 2023 Sep 12
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Kevin Quann, Faruk Sacirbegovic, Warren D Shlomchik.
Natalizumab for GVHD: too little or too late?
Blood advances.
2023 Sep 12;7(17):5187-5188
Mesh Tags
Natalizumab
Substances
Natalizumab
PMID: 37698891
View Full Text